178
Views
31
CrossRef citations to date
0
Altmetric
Original Research

Undertreatment of COPD: a retrospective analysis of US managed care and Medicare patients

, , , &
Pages 1-9 | Published online: 18 Jan 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (27)

Daniel Puebla Neira, Mohammed Zaidan, Shawn Nishi, Alexander Duarte, Christopher Lau, Sairam Parthasarathy, Jiefei Wang, Yong-Fang Kuo & Gulshan Sharma. (2023) Healthcare Utilization in Patients with Chronic Obstructive Pulmonary Disease Discharged from Coronavirus 2019 Hospitalization. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 1827-1835.
Read now
Jennifer Quint, Jukka Montonen, Dave Singh, Herbert Wachtel, Sharon Attick, Swetha Palli, Monica Frazer, Vincent Willey & Glenn Giessel. (2022) New insights into the optimal management of COPD: extracts from CHEST 2021 annual meeting (October 17–20, 2021). Expert Review of Respiratory Medicine 16:4, pages 485-493.
Read now
Alpesh N. Amin, Sharon Cornelison, J. Andrew Woods & Nicola A. Hanania. (2022) Managing hospitalized patients with a COPD exacerbation: the role of hospitalists and the multidisciplinary team. Postgraduate Medicine 134:2, pages 152-159.
Read now
Dave Singh, Steve Holmes, Claire Adams, Mona Bafadhel & John R Hurst. (2021) Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3009-3016.
Read now
Rachel Pullen, Marc Miravitlles, Anita Sharma, Dave Singh, Fernando Martinez, John R Hurst, Luis Alves, Mark Dransfield, Rongchang Chen, Shigeo Muro, Tonya Winders, Christopher Blango, Hana Muellerova, Frank Trudo, Paul Dorinsky, Marianna Alacqua, Tamsin Morris, Victoria Carter, Amy Couper, Rupert Jones, Konstantinos Kostikas, Ruth Murray & David B Price. (2021) CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD Care. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2301-2322.
Read now
Xiaomeng Xu, Dominique Milea, Aldo Amador Navarro Rojas, Anthony Braganza, Tim Holbrook, Brett Marett, Robert Young, Raewyn J Scott & Barry Gribben. (2021) A Real-World Analysis of Treatment Patterns and Clinical Characteristics Among Patients with COPD Who Initiated Multiple-Inhaler Triple Therapy in New Zealand. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1835-1850.
Read now
Morgan Justice Fuoco, Richard A Mularski, Benjamin Wu, Chad Moretz, Mary Ann McBurnie, Richard H Stanford, Phillip Crawford, Daniel Gratie & Bianca Salas. (2021) Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2755-2767.
Read now
Bartolome R Celli, Maryam Navaie, Zhun Xu, Soojin Cho-Reyes, Carole Dembek & Todd P Gilmer. (2019) Medication management patterns among Medicare beneficiaries with chronic obstructive pulmonary disease who initiate nebulized arformoterol treatment. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1019-1031.
Read now
Ioanna Tsiligianni, Maria Kampouraki, Despo Ierodiakonou, Ioannis Poulonirakis & Polyvios Papadokostakis. (2019) COPD patients’ characteristics, usual care, and adherence to guidelines: the Greek UNLOCK study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 547-556.
Read now
Meng-Jer Hsieh, Shu-Yi Huang, Tsung-Ming Yang, Chi-Wei Tao, Shih-Lung Cheng, Chao-Hsien Lee, Ping-Hung Kuo, Yao-Kuang Wu, Ning-Hung Chen, Wu-Huei Hsu, Jeng-Yuan Hsu, Ming-Shian Lin, Chin-Chou Wang, Yu-Feng Wei & Ying-Huang Tsai. (2018) The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2949-2959.
Read now
Alejandro Casas, Maria Montes de Oca, Ana MB Menezes, Fernando C Wehrmeister, Maria Victorina Lopez Varela, Laura Mendoza, Larissa Ramírez & Marc Miravitlles. (2018) Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1545-1556.
Read now
Robert A Wise, Peter MA Calverley, Kerstine Carter, Emmanuelle Clerisme-Beaty, Norbert Metzdorf & Antonio Anzueto. (2018) Seasonal variations in exacerbations and deaths in patients with COPD during the TIOSPIR® trial. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 605-616.
Read now
Brian W. Carlin, Sandra K. Schuldheisz, Imre Noth & Gerard J. Criner. (2017) Individualizing the selection of long-acting bronchodilator therapy for patients with COPD: considerations in primary care. Postgraduate Medicine 129:7, pages 725-733.
Read now
Jason C Simeone, Rakesh Luthra, Shuchita Kaila, Xiaoyun Pan, Tarun D Bhagnani, Jieruo Liu & Teresa K Wilcox. (2017) Initiation of triple therapy maintenance treatment among patients with COPD in the US. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 73-83.
Read now
Hussein D Foda, Anthony Brehm, Karen Goldsteen & Norman H Edelman. (2017) Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 209-214.
Read now
Amol D Dhamane, Phil Schwab, Sari Hopson, Chad Moretz, Srinivas Annavarapu, Kate Burslem, Andrew Renda & Shuchita Kaila. (2017) Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 115-122.
Read now
Jamie Falk, Natalia Dik & Shawn Bugden. (2016) An evaluation of early medication use for COPD: a population-based cohort study. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 3101-3108.
Read now
Anna D Coutinho, Tasneem Lokhandwala, Robert L Boggs, Anand A Dalal, Pamela B Landsman-Blumberg, Julie Priest & David A Stempel. (2016) Prompt initiation of maintenance treatment following a COPD exacerbation: outcomes in a large insured population. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 1223-1231.
Read now
Gregory B Diette, Anand A Dalal, Anna O D’Souza, Orsolya E Lunacsek & Saurabh P Nagar. (2015) Treatment patterns of chronic obstructive pulmonary disease in employed adults in the United States. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 415-422.
Read now
Georgios Hillas, Fotis Perlikos, Ioanna Tsiligianni & Nikolaos Tzanakis. (2015) Managing comorbidities in COPD. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 95-109.
Read now
Christine L Baker, Kelly H Zou & Jun Su. (2014) Long-acting bronchodilator use after hospitalization for COPD: an observational study of health insurance claims data. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 431-439.
Read now
Mayank Ajmera, Amit D Raval, Chan Shen & Usha Sambamoorthi. (2014) Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 339-348.
Read now
Aaron Galaznik, Jonathan Chapnick, Jeffrey Vietri, Shivani Tripathi, Kelly H Zou & Geoffrey Makinson. (2013) Burden of smoking on quality of life in patients with chronic obstructive pulmonary disease. Expert Review of Pharmacoeconomics & Outcomes Research 13:6, pages 853-860.
Read now
Vamsi Bollu, Flavia Ejzykowicz, Krithika Rajagopalan, John Karafilidis & Joel W. Hay. (2013) Risk of all-cause hospitalization in COPD patients initiating long-acting or short-acting beta agonist therapy. Journal of Medical Economics 16:8, pages 1082-1088.
Read now
Azza AbuDagga, Shawn X Sun, Hiangkiat Tan & Caitlyn T Solem. (2013) Exacerbations among chronic bronchitis patients treated with maintenance medications from a US managed care population: an administrative claims data analysis. International Journal of Chronic Obstructive Pulmonary Disease 8, pages 175-185.
Read now
Stephen Rennard, Byron Thomashow, James Crapo, Barbara Yawn, Andrew McIvor, Scott Cerreta, John Walsh & David Mannino. (2013) Introducing the COPD Foundation Guide for Diagnosis and Management of COPD, Recommendations of the COPD Foundation. COPD: Journal of Chronic Obstructive Pulmonary Disease 10:3, pages 378-389.
Read now
Ian M Breunig, Fadia T Shaya & Steven M Scharf. (2012) Delivering cost–effective care for COPD in the USA: recent progress and current challenges. Expert Review of Pharmacoeconomics & Outcomes Research 12:6, pages 725-731.
Read now

Articles from other publishers (4)

Tham Thi Le, Siyeon Park, Michelle Choi, Marniker Wijesinha, Bilal Khokhar & Linda Simoni-Wastila. (2020) Respiratory events associated with concomitant opioid and sedative use among Medicare beneficiaries with chronic obstructive pulmonary disease. BMJ Open Respiratory Research 7:1, pages e000483.
Crossref
Greta Ragaišienė, Rūta Kibarskytė, Rasa Gauronskaitė, Monika Giedraitytė, Agnė Dapšauskaitė, Vytautas Kasiulevičius & Edvardas Danila. (2019) Diagnosing COPD in primary care: what has real life practice got to do with guidelines?. Multidisciplinary Respiratory Medicine 14:1.
Crossref
Jason C. Simeone, Beth L. Nordstrom, Kwame Appenteng, Samuel Huse & Milbhor D’Silva. (2017) Replication of Mini-Sentinel Study Assessing Mirabegron and Cardiovascular Risk in Non-Mini-Sentinel Databases. Drugs - Real World Outcomes 5:1, pages 25-34.
Crossref
Beatrice Huang, Rachel Willard-Grace, Denise De Vore, Jessica Wolf, Chris Chirinos, Stephanie Tsao, Danielle Hessler, George Su & David H. Thom. (2017) Health coaching to improve self-management and quality of life for low income patients with chronic obstructive pulmonary disease (COPD): protocol for a randomized controlled trial. BMC Pulmonary Medicine 17:1.
Crossref